LASEROPTEK Co Ltd, a developer and manufacturer of laser devices for aesthetic and medical dermatology, announces the launch of its PALLAS Solid-State 311nm UVB laser in the United States.
Challenges in the diagnosis of atopic dermatitis (AD) in infants were outlined in study data published in the British Journal of Dermatology, according to Dermatology Advisor.
The American Society of Plastic Surgeons (ASPS) has released supplemental data for its 2022 procedural statistics, revealing generational trends, increasing male interest in minimally invasive procedures, and fluctuating surgeon fees, with an emphasis on safety and authenticity in the pursuit of beauty and self-confidence.
Researchers may be able to provide a non-invasive alternative to skin biopsy to correctly distinguish between two highly inflammatory diseases, they suggest in a media release.
Read More
Researchers at the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute (VCHRI) have identified a key enzyme that contributes to eczema, which may lead to better treatment to prevent the skin disorder’s debilitating effects.
Read More
A newly developed validated Investigator Global Assessment (IGA) atopic dermatitis (AD) scale, accompanied by a training video, demonstrated strong reliability for assessing severity of AD in a recent study, according to Dermatology Advisor.
Read More
Hoth Therapeutics Inc announces that it has obtained exclusive worldwide licensing rights to the BioLexa Platform, a proprietary, patented antimicrobial therapy focused on treating atopic dermatitis.
Read More
Encouraging results from preclinical and healthy volunteer studies for RPT193 were presented at the Society for Investigative Dermatology (SID) Meeting. RPT193 is an oral therapy in development for the treatment of atopic dermatitis and other allergic inflammatory diseases, BioSpace reports.
Read More
Results of emerging research highlight the association of skin pain with atopic dermatitis, including recent studies reporting skin pain in 43% to 78% of patients with eczema, according to Dermatology Advisor.
Read More
People of color are persistently underrepresented in global atopic dermatitis (AD) clinical trials, according to a research letter published in the British Journal of Dermatology.
Read More
A new, modified version of the patient-oriented (PO) SCORing for Atopic Dermatitis (SCORAD) tool is as effective for evaluating atopic dermatitis (AD) in black skin as a previous version used in European countries for white skin, according to a validation study, per Dermatology Advisor.
Read More
Among patients with atopic dermatitis, apple cider vinegar soaks did not enhance skin barrier integrity significantly, but did lead to skin irritation in most subjects, a pilot split‐arm study found, MedPage Today reports.
Read MoreThe global atopic dermatitis treatment market will more than double in value from $3.6 billion in 2014 to an estimated $7.3 billion by 2024.
Read MoreThe American Academy of Dermatology recently released new recommendations regarding dermatologic tests and treatments that are not always necessary. This marks the Academy’s second list developed as part of the Choosing Wisely® campaign, an ABIM Foundation initiative designed to help patients avoid care that may be unnecessary for them.
Read More
New guidelines from The AAD call for a more proactive approach to the management of adult and pediatric atopic dermatitis.
Read More